Literature DB >> 9523241

Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.

A Ota1, X Liu, H Fujio, N Sakato, S Ueda.   

Abstract

Twenty monoclonal antibodies (MAbs) were obtained by immunizing Balb/c mice with recombinant p17 (rp17) of HIV-1. Epitope specificity of each MAb was determined using six peptides that cover the entire region of p17. We found that each MAb reacts with only one of the peptides, residues 12-29, 30-52, 53-87, and 87-115 (P12-29, P30-52, P53-87, P87-115) of p17 with the exception of one MAb. Three kinds of MAbs that recognize P30-52, P87-115, and a conformational epitope, suppressed the infectivity of HIV-1 (JMH-1) when they added in the culture of MT-4 cells infected by HIV-1 within 24 h of the infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523241     DOI: 10.1089/hyb.1998.17.73

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity.

Authors:  Masahisa Ohishi; Takashi Nakano; Sayuri Sakuragi; Tatsuo Shioda; Kouichi Sano; Jun-ichi Sakuragi
Journal:  Nucleic Acids Res       Date:  2010-12-23       Impact factor: 16.971

2.  Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.

Authors:  Francesca Caccuri; Maria Luisa Iaria; Federica Campilongo; Kristen Varney; Alessandro Rossi; Stefania Mitola; Silvia Schiarea; Antonella Bugatti; Pietro Mazzuca; Cinzia Giagulli; Simona Fiorentini; Wuyuan Lu; Mario Salmona; Arnaldo Caruso
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

3.  Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.

Authors:  Valentine U Chukwuma; Mark D Hicar; Xuemin Chen; Katherine J Nicholas; Amanda Joyner; Spyros A Kalams; Gary Landucci; Donald N Forthal; Paul W Spearman; James E Crowe
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.